01Core principlesThe concepts and mechanisms needed to understand the subject.
Surveillance has three simultaneous jobs. First, it detects failure of the treated arterial segment before irreversible tissue loss, rupture or graft occlusion. Second, it tracks the patient’s function, wounds and quality of life, because a patent reconstruction can still fail to achieve the clinical goal. Third, it maintains cardiovascular prevention in a population at high risk of myocardial infarction, stroke and disease progression elsewhere. The plan starts with a postoperative anatomical and haemodynamic baseline, then changes with the conduit, device, indication, early imaging and whether a detected lesion would prompt treatment.
For revascularisation performed for intermittent claudication, lower-limb vein grafts deserve particular attention because stenoses can be silent until thrombosis. Clinical review and ABI alone may miss them, while duplex can localise and grade a treatable lesion. Evidence for routine duplex-triggered re-intervention after every lower-limb endovascular procedure is less secure, so imaging intensity should reflect below-knee location, device, symptoms and local validated pathways. Aortic repair is different: early EVAR CTA assesses endoleak and seal, permitting risk stratification, but late failure means long-term imaging remains necessary. Open aortic repair is durable yet can develop late para-anastomotic or non-contiguous aneurysms.
Key points
- New ischaemic, bleeding, infective or rupture symptoms bypass routine follow-up: arrange urgent vascular assessment and targeted duplex or CTA rather than waiting for the scheduled surveillance test.
- After lower-limb revascularisation for intermittent claudication, combine symptoms, wound and pulse examination, ankle or toe pressures and risk-factor review; add duplex for autologous vein grafts and below-knee interventions because clinically silent stenosis can precede occlusion.
- After standard EVAR with a device of proven durability, obtain CTA within 30 days. Low-frequency imaging during the first five years requires no endoleak or compromised seal, anatomy within the device instructions for use, adequate component overlap, at least 10 mm proximal and distal seal, neck diameter no greater than 30 mm, neck angulation no greater than 60°, iliac diameter no greater than 20 mm and no investigational or new device; non-standard and complex EVAR need individualised follow-up, and every EVAR patient needs long-term imaging regardless of initial risk.
- Surveillance is repair-specific: vein bypass, prosthetic bypass, endovascular limb treatment, EVAR and open aortic repair fail by different mechanisms and cannot share one universal imaging schedule.
- A falling ABI or toe pressure, new duplex stenosis, graft-velocity change, endoleak, sac growth, migration or short seal matters only when compared with a documented postoperative baseline and interpreted with symptoms.
- Each visit must maintain secondary prevention: smoking cessation, exercise, blood pressure, lipids, diabetes, foot care, adherence and individualised antithrombotic treatment with bleeding review.
- Image only with a defined question and action threshold; adapt modality for renal impairment, contrast allergy, radiation burden, body habitus and device artefact without abandoning surveillance.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Healed tissue, relief of rest pain or claudication, improved walking and preserved limb function confirm benefit but do not alone prove durable conduit patency.
A reproducible fall in ankle or toe pressure, change in Doppler waveform or pulse loss suggests inflow, conduit or outflow failure and should trigger imaging.
Focal velocity acceleration, low graft flow or changing waveform can identify a developing vein-graft stenosis before symptoms or complete occlusion.
Endoleak, inadequate overlap or seal, migration, component separation, sac enlargement or new branch compromise changes the surveillance or re-intervention pathway.
New fever, graft pain, wound change, pulsatile mass or bleeding requires urgent assessment for graft infection and pseudoaneurysm rather than routine patency review.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Clinical review with pulse, wound and ankle or toe-pressure assessment - Why
- Establish whether perfusion, tissue healing, symptoms and cardiovascular prevention are improving from the postoperative baseline.
- Interpretation and limitations
- New rest pain, tissue loss, pulse change or reproducible pressure decline prompts anatomical imaging; incompressible ankle arteries require toe pressure or another validated perfusion measure.
- 02
Duplex ultrasound of lower-limb reconstruction - Why
- Assess conduit patency, localise stenosis and examine inflow and outflow without contrast or radiation.
- Interpretation and limitations
- Interpret velocity and waveform change using a validated laboratory protocol and prior scans; confirm that a proposed re-intervention targets a haemodynamically important lesion.
- 03
Early post-EVAR CT angiography - Why
- Detect endoleak, measure aneurysm sac, component overlap and seal zones, and establish the risk-stratified follow-up branch.
- Interpretation and limitations
- Direct endoleak, inadequate seal or overlap, outside-instructions anatomy, neck diameter over 30 mm, neck angulation over 60°, iliac diameter over 20 mm, an investigational or new device, or important sac growth requires closer review; the low-frequency branch does not apply to complex EVAR.
- 04
Aortic duplex, contrast-enhanced ultrasound, CT or MR angiography - Why
- Provide long-term EVAR or open-repair surveillance while balancing endoleak sensitivity, device assessment, renal function and radiation.
- Interpretation and limitations
- Duplex or contrast-enhanced ultrasound can assess sac and flow; CT better defines migration, fracture and anatomy, while MRI avoids iodinated contrast but may suffer metal artefact.
- 05
Cardiovascular and functional review - Why
- Measure the whole outcome beyond patency and maintain secondary prevention.
- Interpretation and limitations
- Review blood pressure, lipids, glycaemia, renal function, smoking, activity, medication adherence, bleeding, walking ability and disease-specific quality of life.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked caseSilent stenosis after infra-inguinal vein bypassAfter bypass for intermittent claudication, the operative wound is healed and walking symptoms improved, but the graft remains within the early surveillance period.+
- 1Context: confirm the original indication, target vessel, conduit and postoperative baseline; ask about recurrent claudication, rest pain, wound progress and cardiovascular or bleeding events.
- 2Reasoning: examine the limb and conduit, compare ankle or toe pressure with baseline and perform duplex because a palpable pulse and symptomatic improvement do not exclude a clinically silent graft stenosis.
- 3Action: if duplex shows a haemodynamically important correctable stenosis, review inflow, outflow and technical anatomy promptly with the vascular team rather than waiting for graft thrombosis.
- 4Verification: after observation or intervention, document symptoms, wound, pressures and duplex result, then continue surveillance and secondary prevention through the period when graft failure is concentrated.
02Stable EVAR pathwayEarly CTA risk stratification after standard EVARThe patient is clinically stable after standard EVAR with a proven device, and early CTA is available to classify device, seal, endoleak, morphology and sac risk.+
- 1Confirm whether the repair is standard or complex and compare early CTA with the completion study for endoleak, component overlap, proximal and distal seal, anatomy within device instructions and branch patency.
- 2Low-risk standard EVAR with no endoleak or compromised seal, adequate overlap, at least 10 mm proximal and distal seal, neck diameter no greater than 30 mm, neck angulation no greater than 60°, iliac diameter no greater than 20 mm and no investigational or new device may enter low-frequency early imaging; this branch does not apply to complex EVAR.
- 3High-risk anatomy or type II endoleak warrants closer, commonly annual, CTA or duplex review; direct type I or III endoleak, degrading seal or sac growth over 10 mm prompts secondary-intervention assessment.
- 4Maintain long-term imaging for all EVAR patients because late device failure and disease progression occur even after initially reassuring anatomy.
03Open repair pathwayLong-term review after open aortic reconstructionThe postoperative repair is stable but late anastomotic and remote arterial disease remain possible.+
- 1Establish a postoperative cross-sectional baseline and retain the operative note, graft configuration and anastomotic levels for future comparison.
- 2Consider imaging of the entire aorta and peripheral arteries every five years after open AAA repair, adapted for symptoms, residual disease and treatment intent.
- 3Escalate new saccular or para-anastomotic change for infection assessment and repair planning rather than applying routine native fusiform aneurysm thresholds automatically.
- 4Continue cardiovascular prevention and instruct the patient to seek urgent care for new abdominal or back pain, collapse, gastrointestinal bleeding or pulsatile swelling.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- For lower-limb revascularisation undertaken for intermittent claudication, ESVS illustrates review before three months, at six and 12 months and annually, incorporating examination, ankle or toe pressure, preventive targets and duplex for vein graft or below-knee intervention; do not extrapolate that illustrative schedule unchanged to other indications or reconstruction types.
- For a vein bypass, preserve serial duplex measurements and act on a confirmed important stenosis before occlusion; an isolated value should be checked against graft segment, waveform, symptoms and prior studies.
- After standard EVAR with a device of proven durability, use CTA within 30 days for risk stratification. Low-frequency imaging during the first five years requires no endoleak or compromised seal, anatomy within the device instructions for use, adequate component overlap, at least 10 mm proximal and distal seal, neck diameter no greater than 30 mm, neck angulation no greater than 60° and iliac diameter no greater than 20 mm; it excludes new, investigational and non-standard devices and complex EVAR. Continue long-term imaging regardless of initial risk, suggested about every five years, to detect late device failure and disease progression.
- After open AAA repair, consider cross-sectional imaging of the entire aorta and peripheral arteries every five years to detect para-anastomotic and new aneurysms.
- At every pathway review, record smoking status, exercise, blood pressure, lipid and diabetes control, kidney function, antithrombotic adherence and bleeding, foot protection and patient-reported walking or quality-of-life outcome.
- Escalate immediately for new rest pain, neurological deficit, bleeding, fever with graft pain, enlarging pulsatile mass or sudden abdominal or back pain regardless of the most recent normal surveillance result.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Patency is not the whole outcome
A technically patent graft may not heal tissue or restore walking if distal disease, neuropathy, infection, cardiac limitation or poor rehabilitation remains.
Baseline makes change interpretable
Postoperative pulses, pressure indices, sac diameter, seal length and duplex waveforms provide the reference that turns a later measurement into meaningful progression or stability.
Vein grafts can fail silently
Many stenoses do not cause symptoms or a detectable ABI fall before thrombosis. Duplex adds anatomical and haemodynamic information during the period of greatest failure risk.
Endovascular limb evidence is less certain
Routine duplex-driven re-intervention after every endovascular treatment for intermittent claudication has not shown the same established benefit as vein-graft surveillance; tailor intensity rather than overstate certainty.
Contrast risk changes modality, not purpose
Renal impairment or contrast allergy may favour duplex, contrast-enhanced ultrasound or MRI, but modality limitations must be acknowledged and unresolved device questions still require adequate anatomical imaging.
Surveillance requires treatment intent
Imaging that finds a problem has value only if results can change care. Frailty, preferences and intervention feasibility should shape frequency through shared decision-making, not silent abandonment.
07Common pitfallsFrequent interpretation and management errors.
- 01
Waiting for the next scheduled scan despite acute symptoms converts surveillance into dangerous delay.
- 02
Discharging a patient because pulses are present overlooks silent vein-graft stenosis and systemic cardiovascular risk.
- 03
Using one universal schedule for vein bypass, limb stent, standard EVAR, complex EVAR and open repair ignores different failure mechanisms.
- 04
Calling every type II endoleak a procedural emergency or ignoring sac growth both misread EVAR risk; classify leak type and sac behaviour together.
- 05
Repeating contrast CT without checking renal function, prior findings or the clinical question creates harm without improving surveillance.
- 06
Focusing only on graft images misses smoking, blood pressure, lipids, diabetes, exercise, foot care, medication adherence and bleeding.